TC-G 1006Potent and selective sphingosine-1-phosphate receptor 1 (S1P1) agonist CAS# 1324003-64-6 |
2D Structure
- Nadifloxacin
Catalog No.:BCC4804
CAS No.:124858-35-1
- Calcipotriol monohydrate
Catalog No.:BCC1445
CAS No.:147657-22-5
- Halobetasol Propionate
Catalog No.:BCC4664
CAS No.:66852-54-8
- Dihydroartemisinin
Catalog No.:BCN6264
CAS No.:71939-50-9
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 1324003-64-6 | SDF | Download SDF |
PubChem ID | 54764919 | Appearance | Powder |
Formula | C21H16F3N3O3 | M.Wt | 415.37 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | DMSO : 62.5 mg/mL (150.47 mM; Need ultrasonic) | ||
Chemical Name | 4-methoxy-N-[[4-phenyl-3-(trifluoromethyl)phenyl]carbamoyl]pyridine-3-carboxamide | ||
SMILES | COC1=C(C=NC=C1)C(=O)NC(=O)NC2=CC(=C(C=C2)C3=CC=CC=C3)C(F)(F)F | ||
Standard InChIKey | MLDQTQOMWDNTNN-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C21H16F3N3O3/c1-30-18-9-10-25-12-16(18)19(28)27-20(29)26-14-7-8-15(13-5-3-2-4-6-13)17(11-14)21(22,23)24/h2-12H,1H3,(H2,26,27,28,29) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Potent and selective sphingosine-1-phosphate receptor 1 (S1P1) agonist (EC50 = 35 nM), displays >100-fold selectivity against receptor subtypes S1P2-5. Induces a dose-dependent reduction in circulating blood lymphocyte counts in rodent models. Orally bioavailable. |
TC-G 1006 Dilution Calculator
TC-G 1006 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.4075 mL | 12.0375 mL | 24.0749 mL | 48.1498 mL | 60.1873 mL |
5 mM | 0.4815 mL | 2.4075 mL | 4.815 mL | 9.63 mL | 12.0375 mL |
10 mM | 0.2407 mL | 1.2037 mL | 2.4075 mL | 4.815 mL | 6.0187 mL |
50 mM | 0.0481 mL | 0.2407 mL | 0.4815 mL | 0.963 mL | 1.2037 mL |
100 mM | 0.0241 mL | 0.1204 mL | 0.2407 mL | 0.4815 mL | 0.6019 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
S1P1 Agonist III is a potent and orally active S1P1 agonist with EC50 of 18 nM; no activity on S1P3. IC50 value: 18 nM(EC50) [1] Target: S1P1 agonist When dosed orally at 1 and 3 mg/kg, the azahydroxymethyl analogue 22(HY-12835) achieved statistically significant lowering of circulating blood lymphocytes 24 h postdose. In rats, a dose-proportional increase in exposure was measured when 22(HY-12835) was dosed orally at 2 and 100 mg/kg. 22 displayed excellent pharmacokinetic parameters with low clearance (CL = 0.11 L/h/kg), long mean residence time (40 h), and good oral bioavailability (F = 67%).
References:
[1]. Harrington PE, et al. Optimization of a Potent, Orally Active S1P1 Agonist Containing a Quinolinone Core. ACS Med Chem Lett. 2011 Nov 23;3(1):74-8.
- Boc-Gln(Trt)-OH
Catalog No.:BCC3384
CAS No.:132388-69-3
- Boc-Asn(Trt)-OH
Catalog No.:BCC3360
CAS No.:132388-68-2
- Fmoc-Gln(Trt)-OPfp
Catalog No.:BCC3486
CAS No.:132388-65-9
- Fmoc-Asn(Trt)-OPfp
Catalog No.:BCC3082
CAS No.:132388-64-8
- Z-Gln(Trt)-OH
Catalog No.:BCC2782
CAS No.:132388-60-4
- Fmoc-Asn(Trt)-OH
Catalog No.:BCC3081
CAS No.:132388-59-1
- H-Asn(Trt)-OH
Catalog No.:BCC2878
CAS No.:132388-58-0
- 10-Hydroxyneoline
Catalog No.:BCN6510
CAS No.:132362-42-6
- 5-Acetoxy-7-hydroxyflavone
Catalog No.:BCN6174
CAS No.:132351-58-7
- Methyl isocostate
Catalog No.:BCN6173
CAS No.:132342-55-3
- 4-Epialyxialactone
Catalog No.:BCN6172
CAS No.:132339-37-8
- Benzyl ferulate
Catalog No.:BCN7753
CAS No.:132335-97-8
- β-D-Glucopyranoside,(3β,6α,16β,20R,24S)-3-[(3,4-di-O-acetyl-β-D-xylopyranosyl)oxy]-20, 24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl
Catalog No.:BCC8370
CAS No.:1324005-51-7
- Chrysophanol 8-O-glucoside
Catalog No.:BCN6175
CAS No.:13241-28-6
- Neoeriocitrin
Catalog No.:BCN3271
CAS No.:13241-32-2
- Neohesperidin
Catalog No.:BCN5915
CAS No.:13241-33-3
- Alosetron-d3 Hydrochloride
Catalog No.:BCC1345
CAS No.:1189919-71-8
- 2-TEDC
Catalog No.:BCC6735
CAS No.:132465-10-2
- (Z)-Pugnac
Catalog No.:BCC5333
CAS No.:132489-69-1
- Olanzapine
Catalog No.:BCC5042
CAS No.:132539-06-1
- 15-Demethylplumieride
Catalog No.:BCN6176
CAS No.:132586-69-7
- Bruceanic acid C
Catalog No.:BCN7999
CAS No.:132587-60-1
- CCMQ
Catalog No.:BCC6984
CAS No.:132623-44-0
- Otophylloside O
Catalog No.:BCN7337
CAS No.:1326583-08-7
4-Methoxy-N-[2-(trifluoromethyl)biphenyl-4-ylcarbamoyl]nicotinamide: A Potent and Selective Agonist of S1P1.[Pubmed:24900263]
ACS Med Chem Lett. 2011 Jul 29;2(10):752-7.
The sphingosine-1-phosphate-1 receptor (S1P1) and its endogenous ligand sphingosine-1-phosphate (S1P) cooperatively regulate lymphocyte trafficking from the lymphatic system. Herein, we disclose 4-methoxy-N-[2-(trifluoromethyl)biphenyl-4-ylcarbamoyl]nicotinamide (8), an uncommon example of a synthetic S1P1 agonist lacking a polar headgroup, which is shown to effect dramatic reduction of circulating lymphocytes (POC = -78%) in rat 24 h after a single oral dose (1 mg/kg). The excellent potency that 8 exhibits toward S1P1 (EC50 = 0.035 muM, 96% efficacy) and the >100-fold selectivity that it displays against receptor subtypes S1P2-5 suggest that it may serve as a valuable tool to understand the clinical relevance of selective S1P1 agonism.